Advertisement

Topics

CANCER DRUG MAY BENEFIT PATIENTS WITH INHERITED FORM OF KIDNEY DISEASE

17:00 EDT 24 Aug 2017 | American Society of Nephrology

A tyrosine kinase inhibitor approved for the treatment of certain cases of chronic myeloid leukemia slowed cyst growth in patients with autosomal dominant polycystic kidney disease.

Original Article: CANCER DRUG MAY BENEFIT PATIENTS WITH INHERITED FORM OF KIDNEY DISEASE

NEXT ARTICLE

More From BioPortfolio on "CANCER DRUG MAY BENEFIT PATIENTS WITH INHERITED FORM OF KIDNEY DISEASE"

Advertisement
Quick Search
Advertisement
Advertisement